Fentanyl activates a particular population of vagal efferents which are cardioinhibitory
- 1 May 1980
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 312 (1), 57-61
- https://doi.org/10.1007/bf00502575
Abstract
In order to determine whether and how opiates affect vagal efferents, effects of fentanyl on single fibre discharge in the cervical vagus in dogs were studied. Dependent upon the responses to induced increases in blood pressure, 3 types of vagal efferents were classified: Type A (n=9) with an increase, type B (b=4) with a decrease and type C (n=27) with no change in rate of discharge. Fentanyl (0.01 mg/kg i.v.) activated type A efferents which are considered as cardioinhibitory, but it did not activate type B and type C efferents. The activation was antagonized by naloxone. Cumulative doses of fentanyl (0.0025–0.16 mg/kg i.v.) produced a progressive increase in the discharge rate of type A efferents and a decrease in heart rate. These effects were maximum at 0.04 mg/kg (n=7). Blood pressure was only slightly affected. The changes in discharge rate and heart rate were strongly and negatively correlated (r=−0.82, P<0.001). At maximum cardioinhibitory effects of fentanyl, blood pressure increases were able to further activate type A efferents and to decrease heart rate. The results show that fentanyl acts differentially on various vagal efferents. Only type A (cardioinhibitory) efferents are activated. It is hypothesized that the opiate receptor system in the brain plays a physiological role in the control of heart rate.Keywords
This publication has 19 references indexed in Scilit:
- Perfusion of the fourth cerebral ventricle with fentanyl induces naloxone-reversible bradycardia, hypotension, and EEG synchronisation in conscious dogsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Pharmacokinetics of 3H-Fentanyl in the Dog Anesthetized with EnfluraneAnesthesiology, 1979
- Central Vagal Control of Fentanyl-Induced Bradycardia During Halothane AnesthesiaAnesthesia & Analgesia, 1978
- Central cardiovascular effects of morphinomimetic peptides in dogsEuropean Journal of Pharmacology, 1977
- Enkephalin pentapeptides — A review of current evidence for a physiological role in vertebrate neurotransmissionLife Sciences, 1977
- Central sites and mechanisms of the hypotensive and bradycardic effects of the narcotic analgesic agent fentanylNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1977
- Endorphins, Brain Peptides That Act like OpiatesNew England Journal of Medicine, 1977
- Cardiovascular Dynamics After Large Doses of Fentanyl and Fentanyl Plus N2O in the DogAnesthesia & Analgesia, 1976
- Cardiovascular Effects of Minimal Analgesic Quantities of Innovar??, Fentanyl, and Droperidol in ManAnesthesia & Analgesia, 1975
- Centrally mediated bradycardia and hypotension induced by narcotic analgesics: Dextromoramide and fentanylEuropean Journal of Pharmacology, 1974